Skip to main content
Premium Trial:

Request an Annual Quote

Soane BioSciences Appoints President

Premium

HAYWARD, Calif.--Soane BioSciences announced the appointment of Joseph Limber as president and CEO. Limber, who has 23 years pharmaceutical industry experience, was most recently president and CEO at Praecis Pharmaceuticals, a private company in Cambridge, Mass., that has discovered several novel drugs utilizing a proprietary high-throughput screening and optimization technology platform.

Prior to joining Praecis, Limber served as executive vice-president at Sequis Pharmaceuticals in Menlo Park, Calif., where he negotiated corporate partnerships worldwide and contributed to several public financings.

Soane applies advances in microfabrication and microfluidics to develop new tools for drug discovery and genomics. By performing integrated sample processing and analysis on microfluidic chips, these tools enable the rapid, parallel processing of large numbers of samples requiring only minute volumes of expensive or rare reagents.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.